pharmaceutical · input

Penicillin G (Pen G)

Primary fermentation output from Penicillium chrysogenum; feedstock for enzymatic conversion to 6-APA nucleus used in all penicillin-class antibiotics.

3

Source countries

3

Companies

1

Goods affected

0

Claims on record

What depends on it

Goods that need this input

1 essential American goods rely on penicillin g (pen g) somewhere upstream in their supply chain.

Where it comes from

Source countries

Share of global supply, by country.

CountryShare of supply
CNChina82%
ATAustria/EU5%
INIndia5%

Who makes it

Supplier companies

3 companies produce penicillin g (pen g).

North China Pharmaceutical (NCPC)

HQ CN20% share

Second-largest penicillin enterprise globally and the largest Chinese producer of penicillin, amoxicillin, 6-APA, and streptomycin. Annual capacity: 7,000–8,000 tonnes antibiotics, 5,000 tonnes intermediates.

CSPC Pharmaceutical Group(1093.HK)

HQ CN18% share

Major Chinese pharmaceutical conglomerate with world-class fermentation infrastructure. Key producer of penicillin G, cephalosporin APIs, and 6-APA. Operates large bioreactors in Shandong and Hebei.

Aurobindo Pharma Limited(AUROPHARMA.NS)

HQ IN3% share

Indian generic pharmaceutical company (NSE: AUROPHARMA; HQ Hyderabad, Telangana; ~$3.8B revenue); one of the world's largest generic API and finished dose manufacturers. Aurobindo holds INCB quota approvals for buprenorphine API manufacture in India and exports to regulated markets (US, EU). Aurobindo's controlled substance API operations leverage India's generic pharmaceutical industrial base to serve the post-patent-cliff buprenorphine/naloxone generic market. The company's API and formulation business spans more than 150 drug categories; buprenorphine is produced within its active pharmaceutical ingredients division alongside other Schedule II controlled substances (methadone, tramadol, fentanyl intermediates). Indian buprenorphine API production for export is constrained by INCB country-level quota allocations that limit the aggregate quantity India is authorized to manufacture annually. Aurobindo also produces buprenorphine/naloxone finished dose sublingual films and tablets at its US FDA-approved facilities, sourcing API from its own manufacturing or from other qualified suppliers.